Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0D4IJ
|
||||
Former ID |
DNC013802
|
||||
Drug Name |
N-Hexylcarbamic Acid Biphenyl-3-yl Ester
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529498] | ||
Structure |
Download2D MOL |
||||
Formula |
C19H23NO2
|
||||
Canonical SMILES |
CCCCCCNC(=O)OC1=CC=CC(=C1)C2=CC=CC=C2
|
||||
InChI |
1S/C19H23NO2/c1-2-3-4-8-14-20-19(21)22-18-13-9-12-17(15-18)16-10-6-5-7-11-16/h5-7,9-13,15H,2-4,8,14H2,1H3,(H,20,21)
|
||||
InChIKey |
QPTMPZNXKZNQMF-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529498] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.